Civic Intelligence

Almeida Molecular Imaging Foundation Corporation

990EZ • Fiscal year 2018 • EIN 46-4656040

Jan 01, 2018 to Dec 31, 2018 • Filed on Nov 13, 2019

Organization ProfileWWW.AMIFUND.ORG
38484 N 94th StScottsdale, AZ 85262

(520) 661-5125

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Liabilities / Revenue

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Net Margin

2nd percentile

-358%

Higher net margin than 2% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Asset Growth

5th percentile

-71%

Faster asset growth than 5% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Annualized from 2017 to 2018

Revenue Growth

3rd percentile

-89%

Faster revenue growth than 3% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Annualized from 2017 to 2018

Balance Sheet
Liabilities / Assets57th percentile

Assets

Down

$15,790

Down $38,732 (-71%) from 2017

Net Assets

Down

$15,790

Down $38,732 (-71%) from 2017

Liabilities

Flat

$0

Flat from 2017

Revenue And Expenses
Liabilities / Revenue56th percentileNet Margin2nd percentile

Revenue

Down

$10,830

Down $83,982 (-89%) from 2017

Expenses

Down

$49,562

Down $71,859 (-59%) from 2017

Net Income

Down

-$38,732

Down $12,123 (-46%) from 2017

Historical Trend

Balance Sheet Trend

Asset Growth5th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200K$150K$100K$50K$0Assets 2014: $4,633Liabilities 2014: $0Net Assets 2014: $4,6332014Assets 2015: $151,686Liabilities 2015: $0Net Assets 2015: $151,6862015Assets 2016: $81,131Liabilities 2016: $0Net Assets 2016: $81,1312016Assets 2017: $54,522Liabilities 2017: $0Net Assets 2017: $54,5222017Assets 2018: $15,790Liabilities 2018: $0Net Assets 2018: $15,7902018

Highlighted filing

2018

Assets$15,790
Liabilities$0
Net Assets$15,790
Open 2018 Filing

Operations Trend

Revenue Growth3rd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$300K$200K$100K$0-$100KRevenue 2014: $55,300Expenses 2014: $50,667Net Income 2014: $4,6332014Revenue 2015: $241,476Expenses 2015: $94,423Net Income 2015: $147,0532015Revenue 2016: $100,886Expenses 2016: $171,441Net Income 2016: -$70,5552016Revenue 2017: $94,812Expenses 2017: $121,421Net Income 2017: -$26,6092017Revenue 2018: $10,830Expenses 2018: $49,562Net Income 2018: -$38,7322018

Highlighted filing

2018

Revenue$10,830
Expenses$49,562
Net Income-$38,732
Open 2018 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Signed
Nov 13, 2019
Return Version
2018v3.1
Gross Receipts
$10,830
Mission and Program Overview

Mission

Cancer public awareness, education, patient empowerment and research, with special emphasis on prostate cancer.

Program Services

DescriptionGrantsExpenses
CLINICAL TRIAL: PET IMAGING CHARACTERISTICS OF C11-ACETATE IN PATIENTS WITH PROSTATE CARCINOMA, DETECTION OF RECURRENT DISEASE WITH PSA RELAPSE. THE GOAL OF THIS STUDY IS IMPROVED IMAGING OF PROSTATE CANCER BY POSITRON EMISSION TOMOGRAPHY (PET) WITH USE OF THE RADIOPHARMACEUTICAL C-11 ACETATE, UTILIZING STATE-OF-THE-ART PET/CT CAMERA TECHNOLOGY AND PROCESSING ALGORITHMS. THE STUDY IS DESIGNED TO GENERATE DATA TO ADD TO THE UNDERSTANDING OF THE EFFECTIVENESS OF C-11 ACETATE, FOCUSING ON PATIENTS WITH RECURRENT OR PERSISTENT DISEASE AFTER PROSTATECTOMY OR RADIATION THERAPY.$0$45,069
CLINICAL TRIAL: C-11 SODIUM ACETATE PET/CT IMAGING FOR METASTATIC DISEASE IN INTERMEDIATE-TO-HIGH RISK PROSTATE ADENOCARCINOMA. THIS CLINICAL TRIAL IS STUDYING HOW THIS IMAGING TEST MAY HELP INFLUENCE THE CHOICE AND EXTENT OF INITIAL AND SUBSEQUENT TREATMENTS.$0$0
CLINICAL TRIAL: A PHASE III DOUBLE BLIND, PLACEBO CONTROLLED STUDY WITH A RANDOMIZATION ALLOCATION RATIO OF 1:1. THE STUDY PERIOD CONSISTS OF SCREENING/RANDOMIZATION, TREATMENT, ACTIVE FOLLOW-UP WITH CLINIC VISITS, ACTIVE FOLLOW-UP WITHOUT CLINIC VISITS, AND LONG-TERM FOLLOW-UP PHASES. IN THIS STUDY, SUBJECTS ARE RECEIVING STUDY TREATMENT.$0$0
Compensation and Service Providers
Top Officer Pay76th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
FABIO ALMEIDAPresidentPT$0--
CYNTHIA ALMEIDAVice President-$0--
ELISA BLACKWELLSecretary-$0--
Filing and Contact Details

Filer

Filer Name
Almeida Molecular Imaging Foundation
EIN
46-4656040
Phone
5206615125
Address
38484 N 94TH ST, SCOTTSDALE, AZ 85262

Signing Officer

Name
Fabio Almeida
Title
President
Phone
5206615125
Signed
2019-11-13
Discuss with paid preparer
Yes

Preparer

Firm
Upworth Pllc
Address
2141 E HIGHLAND AVE SUITE A-100, PHOENIX, AZ 85016
Preparer
Kevin Eyman
Phone
6027737650
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 4 - Other Investment Income

“Description: interest . Amount: 5.”

Form 990-ez, Part I, Line 16 - Other Expenses

“Description: research support. Amount: 45,000. Description: insurance. Amount: 1,993. Description: credit card fees. Amount: 69. Total to form 990-ez, line 16: 47,062.”

Raw XML Appendix157 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum05206615125
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt038484 N 94TH ST
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SCOTTSDALE
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0AZ
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd085262
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt054522
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt015790
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt010825
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt0-38732
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt02500
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt054522
IRS990EZ/Form990TotalAssetsGrp/EOYAmt015790
IRS990EZ/GrossReceiptsAmt010830
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InvestmentIncomeAmt05
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt054522
IRS990EZ/NetAssetsOrFundBalancesEOYAmt015790
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt054522
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt015790
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt010.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0FABIO ALMEIDA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1CYNTHIA ALMEIDA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2ELISA BLACKWELL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1VICE PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2SECRETARY
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt047062
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0CANCER PUBLIC AWARENESS, EDUCATION, PATIENT EMPOWERMENT AND RESEARCH, WITH SPECIAL EMPHASIS ON PROSTATE CANCER.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0CLINICAL TRIAL: PET IMAGING CHARACTERISTICS OF C11-ACETATE IN PATIENTS WITH PROSTATE CARCINOMA, DETECTION OF RECURRENT DISEASE WITH PSA RELAPSE. THE GOAL OF THIS STUDY IS IMPROVED IMAGING OF PROSTATE CANCER BY POSITRON EMISSION TOMOGRAPHY (PET) WITH USE OF THE RADIOPHARMACEUTICAL C-11 ACETATE, UTILIZING STATE-OF-THE-ART PET/CT CAMERA TECHNOLOGY AND PROCESSING ALGORITHMS. THE STUDY IS DESIGNED TO GENERATE DATA TO ADD TO THE UNDERSTANDING OF THE EFFECTIVENESS OF C-11 ACETATE, FOCUSING ON PATIENTS WITH RECURRENT OR PERSISTENT DISEASE AFTER PROSTATECTOMY OR RADIATION THERAPY.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1CLINICAL TRIAL: C-11 SODIUM ACETATE PET/CT IMAGING FOR METASTATIC DISEASE IN INTERMEDIATE-TO-HIGH RISK PROSTATE ADENOCARCINOMA. THIS CLINICAL TRIAL IS STUDYING HOW THIS IMAGING TEST MAY HELP INFLUENCE THE CHOICE AND EXTENT OF INITIAL AND SUBSEQUENT TREATMENTS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt2CLINICAL TRIAL: A PHASE III DOUBLE BLIND, PLACEBO CONTROLLED STUDY WITH A RANDOMIZATION ALLOCATION RATIO OF 1:1. THE STUDY PERIOD CONSISTS OF SCREENING/RANDOMIZATION, TREATMENT, ACTIVE FOLLOW-UP WITH CLINIC VISITS, ACTIVE FOLLOW-UP WITHOUT CLINIC VISITS, AND LONG-TERM FOLLOW-UP PHASES. IN THIS STUDY, SUBJECTS ARE RECEIVING STUDY TREATMENT.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt10
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt20
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt045069
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt10
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt20
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SchoolOperatingInd00
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt049562
IRS990EZ/TotalProgramServiceExpensesAmt045069
IRS990EZ/TotalRevenueAmt010830
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0HTTP://WWW.AMIFUND.ORG/
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt010825
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0108550
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0100859
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0241475
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt055300
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0517009
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt05
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt013
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt018
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt0148032
IRS990ScheduleA/SubstantialContributorsTotAmt0368977
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt010825
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0108550
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0100859
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0241475
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt055300
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0517009
IRS990ScheduleA/TotalSupportAmt0517027
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: INTEREST . AMOUNT: 5.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DESCRIPTION: RESEARCH SUPPORT. AMOUNT: 45,000. DESCRIPTION: INSURANCE. AMOUNT: 1,993. DESCRIPTION: CREDIT CARD FEES. AMOUNT: 69. TOTAL TO FORM 990-EZ, LINE 16: 47,062.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 4 - OTHER INVESTMENT INCOME
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02020-03-31 21:24:44Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0FABIO ALMEIDA
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum05206615125
ReturnHeader/BusinessOfficerGrp/SignatureDt02019-11-13
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ALMEIDA MOLECULAR IMAGING FOUNDATION
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0CORPORATION
ReturnHeader/Filer/BusinessNameControlTxt0ALME
ReturnHeader/Filer/EIN0464656040
ReturnHeader/Filer/PhoneNum05206615125
ReturnHeader/Filer/USAddress/AddressLine1Txt038484 N 94TH ST
ReturnHeader/Filer/USAddress/CityNm0SCOTTSDALE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0AZ
ReturnHeader/Filer/USAddress/ZIPCd085262
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId0DA39A3EE5E6B4B0D3255BFEF95601890AFD80709
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId0838C44FC95EED2E72EA7AA0C8BD3B84A16ECEF8C
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt064.38.254.76
ReturnHeader/FilingSecurityInformation/IPDt02019-11-13
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0MS
ReturnHeader/FilingSecurityInformation/IPTm012:01:47
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0452047163
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0UPWORTH PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt02141 E HIGHLAND AVE SUITE A-100
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0PHOENIX
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0AZ
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd085016
ReturnHeader/PreparerPersonGrp/PhoneNum06027737650
ReturnHeader/PreparerPersonGrp/PreparationDt02019-11-13
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0KEVIN EYMAN
ReturnHeader/ReturnTs02019-11-14T14:12:05-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02018-01-01
ReturnHeader/TaxPeriodEndDt02018-12-31
ReturnHeader/TaxYr02018

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2018 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$15,790
Liabilities
$0
Net assets
$15,790
Revenue
$10,830
Expenses
$49,562
Net income
-$38,732
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2018Detailed filing. Detailed filing data is available for this year.$0.16$0.00$0.16$0.11$0.50$0.39
2017Detailed filing. Detailed filing data is available for this year.$0.55$0.00$0.55$0.95$1.21$0.27
2016Detailed filing. Detailed filing data is available for this year.$0.81$0.00$0.81$1.01$1.71$0.71
2015Detailed filing. Detailed filing data is available for this year.$1.52$0.00$1.52$2.41$0.94$1.47
2014Detailed filing. Detailed filing data is available for this year.$0.05$0.00$0.05$0.55$0.51$0.05